title: BAP1 protein is a progression factor in malignant pleural mesothelioma.
abstract: Human malignant pleural mesothelioma (MPM) is an aggressive cancer due to former asbestos exposure with little knowledge about prognostic factors of outcome and resistance to conventional therapy. BRCA1-associated protein 1 (BAP1) is a tumor suppressor gene that is frequently lost in MPM. Germline mutations of BAP1 predispose to several different tumors including malignant mesothelioma. Our study aimed to clarify if asbestos exposure has an influence on BAP1 expression and if BAP1 expression could be used as a prognostic factor of outcome. An immunohistochemical staining for BAP1 was performed on 123 MPM tissue samples and the expression levels have been correlated with asbestos exposure and overall survival time. BAP1 expression was not associated with asbestos exposure but we detected a significant effect of BAP1 expression on overall survival time--the higher the BAP1 expression (non-mutated BAP1), the shorter the overall survival. BAP1 mutation has been linked to non-asbestos induced familial mesotheliomas, which usually belong to the long survivor group and BAP1 is most probably functioning differently than in sporadic cases. Further investigations need to be performed to characterize the BAP1 mutations and to identify the BAP1 downstream targets in MPM.
authors: Institute of Pathology, Research Unit for Molecular Lung- and Pleura Pathology, Medical University of Graz, Auenbruggerplatz 25, 8036, Graz, Austria, lisa.arzt@medunigraz.at.
authors: Lisa
authors: L
authors: Arzt
authors: Franz
authors: F
authors: Quehenberger
authors: Iris
authors: I
authors: Halbwedl
authors: Thomas
authors: T
authors: Mairinger
authors: Helmut H
authors: HH
authors: Popper
mesh_terms: D001194:Asbestos / Q000009:adverse effects; D018450:Disease Progression; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology*; D008297:Male; D008654:Mesothelioma / Q000235:genetics* / Q000473:pathology*; D000086002:Mesothelioma, Malignant; D009154:Mutation; D010997:Pleural Neoplasms / Q000235:genetics* / Q000473:pathology*; D011379:Prognosis; D025521:Tumor Suppressor Proteins / Q000235:genetics*; D043222:Ubiquitin Thiolesterase / Q000235:genetics*
chemical_list: C400134:BAP1 protein, human; D025521:Tumor Suppressor Proteins; D001194:Asbestos; D043222:Ubiquitin Thiolesterase
references: J Thorac Cardiovasc Surg. 2008 Mar;135(3):620-6, 626.e1-3
references: 18329481
references: Oncogene. 1998 Mar 5;16(9):1097-112
references: 9528852
references: Orphanet J Rare Dis. 2008 Dec 19;3:34
references: 19099560
references: Lung Cancer. 2009 May;64(2):140-7
references: 18835652
references: Virchows Arch. 2008 Dec;453(6):627-35
references: 18958493
references: J Thorac Oncol. 2007 Oct;2(10):957-65
references: 17909360
references: Mol Cancer Ther. 2002 Jul;1(9):687-94
references: 12479365
references: Nat Genet. 2011 Jun 05;43(7):668-72
references: 21642991
references: Int J Biol Markers. 2009 Apr-Jun;24(2):112-7
references: 19634115
references: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14133-8
references: 14617776
references: Cancer Sci. 2012 May;103(5):868-74
references: 22321046
references: Ann N Y Acad Sci. 1999;886:191-4
references: 10667217
references: Expert Opin Emerg Drugs. 2009 Sep;14(3):423-37
references: 19552609
references: Mol Cell Biol. 2009 Apr;29(8):2181-92
references: 19188440
references: J Transl Med. 2012 Aug 30;10:179
references: 22935333
references: Eur J Cardiothorac Surg. 2006 Jan;29(1):14-9
references: 16343925
references: Clin Cancer Res. 2012 Sep 1;18(17):4485-90
references: 22825583
references: J Biol Chem. 2009 Dec 4;284(49):34179-88
references: 19815555
references: Monaldi Arch Chest Dis. 2006 Dec;65(4):210-6
references: 17393666
references: Cell. 2009 Jul 23;138(2):389-403
references: 19615732
references: Lancet. 2004 Sep 25-Oct 1;364(9440):1183-5
references: 15451229
references: W V Med J. 2009 May-Jun;105(3):13-6
references: 19456032
references: Clin Cancer Res. 2003 Jun;9(6):2108-13
references: 12796375
references: Science. 2008 Feb 1;319(5863):620-4
references: 18239126
references: Lung Cancer. 2001 Nov;34(2):279-87
references: 11679187
references: Nat Genet. 2011 Aug 28;43(10):1022-5
references: 21874000
references: Carcinogenesis. 2002 Jun;23(6):1017-24
references: 12082024
references: Semin Thorac Cardiovasc Surg. 2009 Summer;21(2):149-53
references: 19822286
references: Curr Mol Pharmacol. 2009 Jun;2(2):190-206
references: 20021458
references: Nat Cell Biol. 2007 Dec;9(12):1401-12
references: 17994010
references: Cancer Res. 2008 Sep 1;68(17):6953-62
references: 18757409
references: J Clin Oncol. 2012 Nov 10;30(32):e337-40
references: 23032617
references: Nat Genet. 2011 Aug 28;43(10):1018-21
references: 21874003
references: EMBO J. 2002 Dec 16;21(24):6755-62
references: 12485996
references: J Med Genet. 2011 Dec;48(12):856-9
references: 21941004
references: Science. 2010 Dec 3;330(6009):1410-3
references: 21051595